baber/WOPTO huggingface dataset:
Patent TW-202235153-A (TW)
Title: Hollow resin particles for semiconductor member resin composition
Inventor: MATSUURA HARUHIKO
IPC: B01J13/14
Filed: 2021-12-17
Abstract: The present invention provides styrene-based hollow resin particles for a semiconductor member resin composition that make it possible to provide a semiconductor member that achieves excellent low dielectric characteristics as a result of using the semiconductor member resin composition. According to the embodiments, the hollow resin particles for a semiconductor member resin composition have a shell part and a hollow portion that is enclosed by the shell part, the total concentration of the lithium, sodium, potassium, and magnesium included in the hollow resin particles being no more than 200 mg/kg.
Patent TW-202241724-A (TW)
Inventor: LUEDTKE THORSTEN
IPC: B60J10/77
Filed: 2021-12-28
Abstract: 本發明涉及一種機動車輛的側門窗結構(1)，包括一側門，具備一側門窗及一車體區域，該車體區域接近該側門窗佈置，該側門窗可上下移動且無框佈置在該側門中，該側門窗包括至少二玻璃平面件，一內玻璃平面件(2)及一外玻璃平面件(3)，該外玻璃平面件(3)的上端(8)低於該內玻璃平面件(2)的上端(9)，在該側門及該側門窗的一閉合模式下，該外玻璃平面件(3)的一外表面(10)與該車體的一車頂蒙皮(12)的一外表面(11)及/或任何附接該車頂蒙皮(12)的裝飾件齊平佈置，該內玻璃平面件(2)在該側門與該側門窗的閉合位態到達一通道(4)內且該外玻璃平面件(3)被佈置在該通道(4)外。
Patent TW-202326071-A (TW)
Title: Loading stage device and measurement device including the same
Inventor: CHUO CHIN-HSING
IPC: G01B21/00
Filed: 2021-12-29
Abstract: A loading stage device is provided, including: a machine, a first driving module, a second driving module, a first control unit, an encoder and a second control unit; wherein when the second control unit is received respective motor rotation numbers of a first driving motor and a second driving motor of the first driving module which is detected by the encoder, the second control unit converts signals to drive the X axis driving motor to move a first loading platform and to drive the Y axis driving motor to move a second lading platform. A measurement device is further provided, including the loading stage device mentioned above.
Patent TW-202241918-A (TW)
Title: Organic electroluminescent materials and devices
Inventor: MARGULIES ERIC A
IPC: H01L51/00
Filed: 2017-06-20
Abstract: A compound is disclosed that has a metal coordination complex structure having at least two ligands coordinated to the metal; wherein the compound has a first substituent R1 at one of the ligands' periphery; wherein a first distance is defined as the distance between the metal and one of the atoms in R1 where that atom is the farthest away from the metal among the atoms in R1; wherein the first distance is also longer than any other atom-to-metal distance between the metal and any other atoms in the compound; and wherein when a sphere having a radius r is defined whose center is at the metal and the radius r is the smallest radius that will allow the sphere to enclose all atoms in the compound that are not part of R1, the first distance is longer than the radius r by at least 2.9 Å.
Patent TW-202309548-A (TW)
Inventor: FANG YEH-HSUN
IPC: G01S7/481
Filed: 2022-02-24
Abstract: 本揭露揭示了一種用於飛行時間成像系統的影像感測器，其包括具有一光偵測器的至少一主感測器，該光偵測器包括至少部分形成於含鍺材料中的光電接合區，該含鍺材料包括原子百分比數大於50%的鍺；及具有一光偵測器的至少一第二感測器，該光偵測器包括形成於諸如含矽材料的第二材料中的光電接合區，該第二材料包括原子百分比數在0%與50%之間的鍺。主感測器可偵測飛行時間量測訊號且第二感測器可偵測諸如日光的背景光，以校正背景光干擾。
Patent TW-202303151-A (TW)
Title: Biomarkers for determining an immuno-oncology response
Inventor: SERIE DANIEL
IPC: G01N33/574
Filed: 2022-03-08
Abstract: Provided herein are methods, devices, and kits for identifying glycosylated polypeptide biomarkers and signatures for progression of a disease or a condition, such as cancer, or and response of the disease or condition to a treatment, such as treatment with immune checkpoint blockade for cancer. Provided herein are methods of generating glycosylated polypeptide biomarkers and methods of analyzing glycosylated polypeptides using mass spectrometry. Provided herein are methods of validating a model using glycosylated polypeptides for predicting the disease or condition or for making treatment recommendation.
Patent TW-202336453-A (TW)
Title: Battery probing module
Inventor: TAN SHIH-CHING
IPC: G01R31/36
Filed: 2022-03-11
Abstract: The present invention provides a battery probing module for inspecting a battery, defined with a contact surface having a first electrode area and a second electrode area with different polarities. The battery probing module comprises a frame, having opposing top and bottom plates, and a plurality of probe units. Each probe unit comprises a base body, a first probe, and a plurality of second probes. The base body is defined with a top surface and a bottom surface, the top surface is provided with a fixing unit fixed on the bottom plate deflectably. The first probe and the plurality of second probes, disposed on the base body, protrude from the bottom surface for contacting the first electrode are and the second electrode area respecitvely. In a normal direction of the bottom surface, the first probe is within the periphery surrounded by the plurality of second probes.
Patent TW-202228733-A (TW)
Title: Solid preparation, production method and Catalytic Hydrogen evolution method thereof
Inventor: KOBAYASHI HIKARU
IPC: A61P39/06
Filed: 2017-01-23
Abstract: The present invention provides a solid preparation, in which the silicon fine particles is the major ingredient, and it also able to catalysis the hydrogen evolution. In one embodiment of the solid preparation, the major ingredient of the solid preparation is the silicon fine particles with the crystallite diameter in the range of 1- 100 nm and it has the hydrogen evolution ability above 3 ml/g when contact with the aqueous liquid at above pH 7. According to the solid preparation, the silicon fine particles catalysis the hydrogen evolution when contact with the aqueous liquid. Therefore, it is possible to induce the hydrogen evolution by the characteristic as above mentions (e.g., after oral administration and through the stomach, the hydrogen evolution will occur in the digestive tract for contacting the pancreatic secretion at above pH 7).
Patent TW-202302586-A (TW)
Inventor: YANG ANLE
IPC: A61K31/4375
Filed: 2022-04-28
Abstract: 本發明關於作為甲硫胺酸腺苷轉移酶抑制劑的式(I)化合物、其製備方法及其在製藥領域的應用，其中R 1 、R 2 、R 3 和A如說明書和如請求項中所定義。
Patent TW-202302231-A (TW)
Inventor: SHINOHARA TOMOYUKI
IPC: B08B3/04
Filed: 2022-05-31
Abstract: 本發明藉由一面使洗淨器具接觸由第1保持部保持之基板之下表面中央區域，一面使洗淨器具繞中心軸旋轉，而將下表面中央區域洗淨。使洗淨器具接觸藉由第2保持部而旋轉之基板之下表面外側區域，藉此將下表面外側區域洗淨。以如下方式使設置有第2保持部及洗淨器具之可動基座於水平面內移動，即，於第1保持部與第2保持部之間交接基板時，俯視下第1保持部之基準位置與第2保持部之中心軸一致，洗淨下表面中央區域時，俯視下洗淨器具與由第1保持部保持之基板之下表面中央區域重疊，且洗淨器具之中心軸和基板之與中心不同之第1部分一致。
Patent TW-202317128-A (TW)
Title: 治療化療相關的胃腸道副作用的化合物和方法
Inventor: XIANG JIN-NAN
IPC: A61K31/519
Filed: 2022-06-09
Abstract: 本揭露提供了治療化療相關的胃腸道副作用的化合物和方法。本揭露關於CDK抑制劑在製備藥物中的用途，該藥物用於預防、緩解和/或治療受試者中與化療相關的胃腸道副作用。本揭露還提供了使用CDK抑制劑治療化療相關的胃腸道副作用的方法。
Patent TW-202317559-A (TW)
Inventor: HAM YOUNG-JIN
IPC: C07D471/04
Filed: 2022-06-23
Abstract: The present invention relates to a novel compound as a protein kinase inhibitor, a RON inhibitor in particular.
Patent TW-202304818-A (TW)
Title: Molybdenum oxychloride with improved bulk density
Inventor: LIDDLE BRENDAN J
IPC: B01J2/28
Filed: 2020-10-21
Abstract: Molybdenum oxychloride consolidated masses, comprising molybdenum oxychloride and less than 10 wt% binder. The consolidated masses have a bulk density greater than 0.85 g/cc.
Patent TW-202324800-A (TW)
Title: Magnetoresistive tunnel-junction memory element, magnetoresistive random access memory elements for spin-tranfer torque and spin-orbit torque
Inventor: APALKOV DMYTRO
IPC: G11C11/16
Filed: 2022-09-08
Abstract: A magnetoresistive tunnel-junction (MTJ) memory element, magnetoresistive random access memory elements for spin-tranfer torque (STT) and spin-orbit torque (SOT) are provided. The magnetoresistive tunnel-junction (MTJ) memory element includes a magnetic reference layer (RL), a magnetic free layer (FL), a tunneling barrier layer, which extends between the magnetic RL and the magnetic FL, and a diffusion-blocking layer (DBL), which extends on the magnetic FL. The diffusion-blocking layer includes at least one material selected from a group consisting of bismuth (Bi), antimony (Sb), osmium (Os), rhenium (Re), tin (Sn), rhodium (Rh), indium (In), and cadmium (Cd). An oxide capping layer is also provided on the DBL. The oxide capping layer may include at least one of strontium (Sr), scandium (Sc), beryllium (Be), calcium (Ca), yttrium (Y), zirconium (Zr), and hafnium (Hf).
Patent TW-202324498-A (TW)
Title: Foreign substance inspection apparatus, and manufacturing method for exposure apparatus and article characterized by suppressing the reduction of the accuracy in the detection of a foreign substance
Inventor: MAEDA KOHEI
IPC: H01L21/027
Filed: 2022-09-15
Abstract: Disclosed is a foreign substance inspection apparatus that inspects whether a foreign substance exists in the inspection region of a foreign substance to be detected and includes: a light receiving part used to receive the light from a light source for illuminating a foreign substance and then generate the scattered light from the foreign substance ; and a determination part used to determine whether the signal indicating the amount of light received by the light receiving part is within an allowable value and determine that there is a foreign substance in the inspection region if the signal is out of the allowable value. Moreover, the determination part is based on the illumination condition for illuminating the inspection region with the light from the light source to change the allowable value.
Patent TW-202316474-A (TW)
Title: Control method of writing apparatus and writing apparatus
Inventor: FUJISAKI EITA
IPC: H01J37/28
Filed: 2022-09-21
Abstract: A writing apparatus of the embodiments of the present invention is a writing apparatus that irradiates a predetermined position on an irradiation target with multiple charged particle beams to write a predetermined pattern on the irradiation target, the apparatus comprising: a beam generation mechanism configured to generate multiple charged particle beams; a blanking aperture mechanism configured to perform blanking control of the generated multiple charged particle beams; a stage configured to have the irradiation target mounted thereon and to be movable; and a controller configured to control the writing apparatus, wherein the controller controls the blanking aperture mechanism and the stage to move the stage in an in-plane direction of a surface of the irradiation target during a blanking period in preparatory phase for writing.
Patent TW-202334617-A (TW)
Inventor: OREN YONATAN
IPC: G01J3/433
Filed: 2020-12-11
Abstract: Photoreflectance (PR) spectroscopy system and method for accumulating separately a "pump on" light beam and a "pump off" light beam reflecting off a sample. The system comprises: (a) a probe source for producing a probe beam, the probe beam is used for measuring spectral reflectivity of a sample, (b) a pump source for producing a pump beam, (c) at least one spectrometer, (d) a first modulation device to allow the pump beam to alternatingly modulate the spectral reflectivity of the sample, so that, a light beam reflecting from the sample is alternatingly a "pump on" light beam and a "pump off" light beam, (e) a second modulation device in a path of the light beam reflecting off the sample to alternatingly direct the "pump on" light beam and the "pump off" light beam to the at least one spectrometer, and (f) a computer. The photoreflectance (PR) spectroscopy system comprises at least one spectrometer. Wherein in case of a single spectrometer, the single spectrometer projects the "pump on" light beam to at least one row on a CCD and the "pump off" light beam to another row(s) on the CCD, so that "pump on" signals and "pump off" signals are accumulated separately.
Patent TW-202332682-A (TW)
Title: Peptide inhibitors of interleukin-23 receptor
Inventor: MUNCH HENRIK FISCHER
IPC: C07K7/00
Filed: 2022-12-01
Abstract: The present invention relates to compounds that are peptide inhibitors of interleukin-23 receptor (IL-23R) and to their use in the treatment or prevention of a variety of diseases, conditions or disorders, including inflammatory diseases, such as inflammatory bowel disease, such as Crohn's disease, psoriasis, and ulcerative colitis. The compounds have good physical and chemical stability in the gastrointestinal tract.
Patent TW-202330331-A (TW)
Title: Child stroller apparatus
Inventor: Zhu wan-quan
IPC: B62B7/06
Filed: 2023-01-19
Abstract: A child stroller apparatus includes: a first leg frame including a first side segment, and a second leg frame including a second side segment; a handle frame including a third side segment that is respectively connected pivotally to the first and second side segment, the third side segment being pivotally connected to the first side segment via an articulation; a seat assembly coupled to the first side segment; and a linkage including a support bar, a slider and a frame link, wherein the support bar is respectively connected pivotally to the first and second side segment, the slider is coupled to the seat assembly and is slidably connected to the support bar, and the frame link is pivotally connected to the slider, the slider sliding along the support bar during folding and unfolding of the child stroller apparatus.
Patent TW-202325590-A (TW)
Title: 嬰兒車架及其嬰兒車
Inventor: Sun ming-xing
IPC: B62B7/06
Filed: 2020-10-23
Abstract: 一種嬰兒車架，其包含前腳、後腳、上支撐件和下支撐件，前腳和上支撐件樞接，下支撐件和上支撐件樞接，後腳連接於下支撐件，上支撐件與下支撐件之間設有鎖定機構，以將上支撐件和下支撐件鎖定於展開角度，釋鎖鎖定機構可解除上支撐件和下支撐件之間的鎖定。嬰兒車架另包含一連動機構，前腳包含一前腳桿和一前輪元件，前輪元件轉動連接於前腳桿上以形成一第一樞接點，以在前腳桿繞第一樞接點轉動時，帶動前輪元件繞第一樞接點轉動。
Patent UA-37837-A (UA)
Title: Auto-generation dielectric permittivity measuring device
Filed: 2000-04-21
Abstract: The invention relates to measuring engineering and can be used for measurement of dielectric characteristics of different materials at one-side access to object of control. Auto-generation measuring device for electric permittivity includes first and second auto-generators with RC time-master circuits, first switch, high-potential electrodes of measurement and support capacitor indicators placed on one dielectric sublayer, band filter, amplifier-restrictor, integrator and indicator.
Patent UA-51170-A (UA)
Title: Method for diagnostics of chronic gastritis of "a" type (autoimmune gastritis)
Inventor: HAIDAR YURII ADOLFOVYCH
Filed: 2002-01-24
Abstract: The proposed method for diagnostics of chronic gastritis of "A" type consists in using, as an antigen source, cryostatic sections of the mucous membrane of the fundal area of the stomach of a human or white laboratory rat for detecting the antibodies to the parietal cells of the stomach, which are specific for a certain disease, using indirect reaction of immunofluorescence. The preparations for the analysis are produced from the stomach tissue that is preliminarily fixated in 4 % paraformaldehyde solution and finally fixated in liquefied nitrogen. Then the preparations are treated with the patient's blood serum diluted with a ratio of no less than 1:20. If the immunofluorescence of the secretory channels of the parietal cells of the stomach is detected, chronic gastritis of "A" type (autoimmune gastritis) is predicted.
Patent UA-51484-A (UA)
Title: Composition for cosmetics and prophylaxis
Filed: 2002-04-10
Abstract: The composition for cosmetics and prophylaxis contains the tincture of the pot-marigold, the extract of the birch bracket-fungus, the vaseline, the essential oil, and the base representing the mixture of the vaseline, the water and T2 emulsifier. The composition for cosmetics and prophylaxis also contains the extract of the birch bracket-fungus, the tincture of the hawthorn, the essential oil, and the base representing the mixture of the vaseline, the water and T2 emulsifier.
Patent UA-52345-A (UA)
Title: Method for treating cancer of corpus uteri stage i in elderly patients
Inventor: NESPRIADKO SERHII VALERIIOVYCH
Filed: 2002-04-11
Abstract: The method for treating cancer of corpus uteri stage I in elderly patients comprises hysterectomy including the adnexes and the upper third of the vagina. In addition the iliac lymphadenectomy is performed in cases of intraoperational histological confirmation of the metastatic lesions in the lymph nodes being examined.
Patent UA-49748-A (UA)
Title: Device for measuring elastic characteristics of spring connection terminals
Inventor: HOVORUKHA VOLODYMYR VASYLIOVYCH
Filed: 2002-05-16
Abstract: The proposed device for measuring elastic characteristics of spring connection terminals contains a loading unit, a unit for fixing the connection terminal, and a unit for measuring the connection terminal deformation. In more detail, the proposed device contains a base member, at which two parallel supports are installed symmetrically to the rod of the loading unit. The end walls of each of the supports have L-shaped openings that are positioned opposite to each other. In these openings, in the plane of the support end surfaces, a traverse is installed that supports a pressing plate with an opening for the rod of the loading device. To the rod surface, a stop is fitted. At the base member, an unmovable support with two-arm lever is installed. One of the lever arms interacts with the rod stop, and the other arm interacts with the movable rod of a mechanical motion transducer. On the end surface of the traverse and on the pressing plate, arc-shaped slots are provided. The end parts of the spring connection terminal are inserted into the said slots, so that the longitudinal axis of the rod of the loading unit coincides with the axis of symmetry of the connection terminal.
Patent UA-54276-A (UA)
Title: Method for conservative treatment of pulmonary tuberculosis
Inventor: SAMOSIUK IVAN ZAKHAROVYCH
Filed: 2002-07-10
Abstract: The method for the pathogenetic treatment of the pulmonary tuberculosis comprises the drug therapy and physiotherapy. Ultrasound and magnetic therapy is employed. First the patient is exposed to the ultrasound of 22-44 kGz frequency at the output power of 0.2-1 W/cm2 with the wavelength of 2-5 m. The paravertebral areas on the both sides from Тh1-Th4 vertebrae are exposed to the ultrasound. When the lower lobes are involved the vertebrae down to Th6 are also exposed. At the same time the projections of the pathologic areas to the thoracic cage are also treated. The initial exposure time is 1 minute per one field with gradual increase up to 5 minutes per one field. The integral exposure time accounts to 15-20 minutes. The ultrasound therapy is immediately followed by the magnetic therapy with the parameters of exposure such as follows: the magnetic induction is 2-15 mT with the modulation frequency from 1 to 100 Hz. The same areas are exposed when the magnetic therapy is performed. The initial exposure time is 3-5 minutes per one field with gradual increase up to 10 minutes per one field. The integral exposure time accounts to 20 minutes. The treatment course comprises 10-12 daily procedures.
Patent AP-1704-A (AP)
Title: Water-soluble powdery or granular compositions based on phenanthridines and their uses.
Inventor: DERRIEU GUY
IPC: A61K31/435
Filed: 2002-01-03
Granted: 2007-01-02
Abstract: The invention relates to compositions which are present in the form of powders or granules which are soluble in small quantities of water and which are intended to permit the complete and rapid dissolution of active compounds, in particular phenanthridines, and to their uses. These compositions comprise, in combination and in pulverulent or granulated form, from 5.0 to 50% w/w of at least one phenanthridine, or one of its pharmaceutically acceptable salts, and from 50 to 95% w/w of at least one water-soluble co-solvent. Uses: prevention and treatment of trypanosomiases in animals, either on their own or as co-infections with other parasites.
Patent DO-P2002000413-A (DO)
Title: Formas cristalinas de la sal de calcio del acido [r- (r*,r*)]-2-(4-fluorofenil)-b,o-dihidroxi-5-(1-metiletil) -3-fenil-4-[fenilamino)carbonil]-1h-pirrol-1- heptanoico (2:1)
Inventor: BYRN STEPHEN ROBERT
IPC: A61P25/28
Filed: 2002-06-05
Abstract: Se describen nuevas formas cristalinas de la sal hemicálcica del ácido [RR*,R*] -2- 4-fluorofenil B O dihidroxi-5- 1-metiletil -3-fenil-4- [ fenilamino carbonil] - 1H-pirrol-1-heptanoico, denominadas Forma V, Forma VI, Forma VII, Forma VIII, Forma IX, Forma X, Forma XI, Forma XII, Forma XIII, Forma XIV, Forma XV, Forma XVI, Forma XVII, Forma XVIII y Forma XIX, que se caracterizan por sus patrones de difracción de rayos X en polvo, RMN de estado sólido y/o espectroscopa de Raman; así corno procedimientos para su preparación y composiciones farmacéuticas de las mismas que son utiles como agentes para el tratamiento de la hiperlipidemia,de la hipercolesterolemia, de la osteporosis y de la enfermedad de alzheimer. mismas, que son útiles como agentes para el tratamiento de la hier1ipidemia, de la hipercolesterolemia, de la osteoporosis y de la enfermedad de Alzheimer.
Patent DO-P2010000278-A (DO)
Title: Procedimiento de cierre del extremo de envolturas tubulares plisadas
Inventor: OLLETA REMON AGUSTIN
IPC: A22C13/00
Filed: 2010-09-14
Abstract: El procedimiento de cierre extremo de envolturas tubulares plisadas comprende el desplisado de una porción terminal de la envoltura tubular en la dirección del eje del bastón, volteo de la porción terminal desplisada para su introducción en el interior de la envoltura, sujeción desde el interior de la envoltura de la porción terminal desplisada, girado de la porción terminal y aplastamiento de la porción terminal girada. Este procedimiento se efectúa a la salida de la línea de plisado (ON-LINE) por lo que se constituye en una fase más de dicha operación, o bien se efectúa fuera de la línea de desplisado (OFF-LINE) como operación al margen del desplisado.
Patent DO-P2011000197-A (DO)
Title: Derivados de arilciclopropilacetamida utiles como activadores de glucoquinasa
Inventor: AGEJAS-CHICHARRO FRANCISCO JAVIER
Filed: 2011-06-17
Abstract: Un compuesto de la fórmula: y composiciones farmacéuticas para el tratamiento de diabetes
Patent DO-P2021000036-A (DO)
Title: Combinaciones para tratamiendo de ehna/ehgna y enfermedades relacionadas
Inventor: WILLIAM PAUL ESLER
IPC: A61P35/00
Filed: 2021-02-25
Abstract: Se describe en la presente la combinación de (S)-2-(5-((3-etoxi-piridin-2-il)oxi)piridin-3-il)-N-(tetrahidrofuran-3-il)pirimidina-5-carboxamida, o una sal farmacéuticamente aceptable de la misma, y ácido 4-(4-(1-isopropil-7-oxo-1,4,6,7-tetrahidrospiro-[indazol-5,4-piperidina]-1-carbonil)-6-metoxipiridin-2-il)benzoico, o sal farmacéuticamente aceptable del mismo, para la fabricación de medicamentos útiles en el tratamiento de enfermedades, incluyendo esteatohepatitis no alcohólica (EHNA), en mamíferos.
Patent EC-SP13012719-A (EC)
Title: Compuesto bicíclico
Inventor: YASUMA TSUNEO
IPC: C07D417/04
Filed: 2013-06-25
Abstract: Resumen La presente invención proporciona un compuesto que tiene una acción inhibidora de ACC, que es de utilidad como un agente para la prevención o el tratamiento de obesidad, diabetes, y similares y que tiene una eficacia superior. La presente invención se refiere a un compuesto representado por la fórmula (I):en donde cada símbolo es como se define en la memoria descriptiva,o una de sus sales.
Patent EE-200300257-A (EE)
Inventor: DOUMA ANNEKE CHRISTIANA
IPC: C12C5/00
Filed: 2001-01-22
Abstract: Barley plants having reduced lipoxygenase-1 enzyme activity are provided, for example, barley plants expressing mutant LOX-1 protein. The barley plants of the invention are useful in the production of plant products such as malt and brewed beverages, particularly beer, having increased stability and reduced T2N potential.
Patent GB-189700208-A (GB)
Title: Improvements in Calendars or Almanacs.
Inventor: WEGHORN STEFAN
Filed: 1897-01-04
Granted: 1897-02-27
Abstract: 2 0 8. W e g h o r n, S. Jan. 4. Calendars.-The sheets a are threaded on rings C, C hooked to the wall support so that they can be turned over, after use, to the back of the others. Each successive sheet is provided with a similarly-dated lateral projection b so placed, relatively, that eight of such projections are visible at a time, and on these memoranda may be written for a future day without removing the current sheet.